25/04/2015 08:31:46 Free Membership Login

I G I News (AMEX:IG)

DateTimeSource
Headline
04/24/20154:32PMPRNUSIGI Laboratories To Hold Conference Call For 1st Quarter 2015 Results
IGI Laboratories To Hold Conference Call For 1st Quarter 2015 Results PR Newswire BUENA, N.J., April 24, 2015 BUENA, N.J., April 24, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on... More...>>
04/13/20154:05PMPRNUSIGI Laboratories To Present At 14th Annual Needham Healthcare Conference On April 14, 2015
IGI Laboratories To Present At 14th Annual Needham Healthcare Conference On April 14, 2015 PR Newswire BUENA, N.J., April 13, 2015 BUENA, N.J., April 13, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting tomorrow at the 14th Annual... More...>>
03/26/20158:00AMPRNUSIGI Laboratories, Inc. Announces First ANDA Submission Of 2015
IGI Laboratories, Inc. Announces First ANDA Submission Of 2015 PR Newswire BUENA, N.J., March 26, 2015 BUENA, N.J., March 26, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its first abbreviated new drug application... More...>>
03/23/20154:05PMPRNUSIGI Laboratories, Inc. Appoints John Celentano to Board of Directors
IGI Laboratories, Inc. Appoints John Celentano to Board of Directors PR Newswire BUENA, N.J., March 23, 2015 BUENA, N.J., March 23, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey-based specialty generic pharmaceutical company, today announced that it has appointed John Celentano to its Board of... More...>>
03/09/201510:30AMPRNUSIGI Laboratories To Present At 27th Annual ROTH Capital Conference On March 9, 2015
IGI Laboratories To Present At 27th Annual ROTH Capital Conference On March 9, 2015 PR Newswire BUENA, N.J., March 9, 2015 BUENA, N.J., March 9, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting today at the 27th Annual ROTH Conference... More...>>
03/07/201512:01PMSEEKInsiderInsights.com Daily Round Up 3/6/15: BK, OAS, GPC, CAPL
http://seekingalpha.com/article/2982236-insiderinsights-com-daily-round-up-3-6-15-bk-oas-gpc-capl?source=partner_advfn More...>>
03/02/201510:02PMSEEKIGI Laboratories' (IG) CEO Jason Grenfell Gardner on Q4 2014 Results - Earnings Call Transcript
http://seekingalpha.com/article/2966536-igi-laboratories-ig-ceo-jason-grenfell-gardner-on-q4-2014-results-earnings-call-transcript?source=partner_advfn More...>>
03/02/20154:01PMPRNUSIGI Laboratories Announces Fourth Quarter And Year End 2014 Results
IGI Laboratories Announces Fourth Quarter And Year End 2014 Results PR Newswire BUENA, N.J., March 2, 2015 BUENA, N.J., March 2, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced its financial results for the fourth quarter and year ended... More...>>
02/27/20158:00AMPRNUSIGI Laboratories To Hold Conference Call For 4th Quarter 2014 Results
IGI Laboratories To Hold Conference Call For 4th Quarter 2014 Results PR Newswire BUENA, N.J., Feb. 6, 2015 BUENA, N.J., Feb. 6, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on Monday... More...>>
02/06/20158:00AMPRNUSIGI Laboratories To Hold Conference Call For 4th Quarter 2014 Results
IGI Laboratories To Hold Conference Call For 4th Quarter 2014 Results PR Newswire BUENA, N.J., Feb. 6, 2015 BUENA, N.J., Feb. 6, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:15 pm ET on Monday... More...>>
01/08/20158:00AMPRNUSIGI Laboratories To Present At 33rd Annual J.P. Morgan Healthcare Conference On January 15, 2015
IGI Laboratories To Present At 33rd Annual J.P. Morgan Healthcare Conference On January 15, 2015 PR Newswire BUENA, N.J., Jan. 8, 2015 BUENA, N.J., Jan. 8, 2015 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting at the 33RD Annual J.P... More...>>
12/23/20148:00AMPRNUSIGI Laboratories, Inc. Announces Three Additional ANDA Submissions
IGI Laboratories, Inc. Announces Three Additional ANDA Submissions IGI Filed Eleven ANDAs in 2014, and IGI Now Has Twenty-Two Applications Pending at the FDA PR Newswire BUENA, N.J., Dec. 23, 2014 BUENA, N.J., Dec. 23, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical... More...>>
12/22/20144:05PMPRNUSIGI Laboratories Announces Closing of Initial Purchasers' Exercise in Full of Option to Purchase an Additional $18.75 Million...
IGI Laboratories Announces Closing of Initial Purchasers' Exercise in Full of Option to Purchase an Additional $18.75 Million Aggregate Principal Amount of 3.75% Convertible Senior Notes Due 2019 PR Newswire BUENA, N.J., Dec. 22, 2014 BUENA, N.J., Dec. 22, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG; "IGI... More...>>
12/17/20147:00AMPRNUSIGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019
IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 PR Newswire BUENA, N.J., Dec. 17, 2014 BUENA, N.J., Dec. 17, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or the "Company") announced today the closing of its offering of $125 million aggregate principal amount... More...>>
12/11/20147:00AMPRNUSIGI Laboratories Announces Pricing of $125 Million of 3.75% Convertible Senior Notes Due 2019
IGI Laboratories Announces Pricing of $125 Million of 3.75% Convertible Senior Notes Due 2019 PR Newswire BUENA, N.J., Dec. 11, 2014 BUENA, N.J., Dec. 11, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or the "Company") announced today the pricing of its $125 million aggregate principal amount of 3.75... More...>>
12/10/20144:05PMPRNUSIGI Laboratories To Present At 25TH Annual Oppenheimer Healthcare Conference On December 11, 2014
IGI Laboratories To Present At 25TH Annual Oppenheimer Healthcare Conference On December 11, 2014 PR Newswire BUENA, N.J., Dec. 10, 2014 BUENA, N.J., Dec. 10, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting at the 25TH Annual... More...>>
12/09/20144:01PMPRNUSIGI Laboratories Announces Proposed Offering of $125 Million of Convertible Senior Notes Due 2019
IGI Laboratories Announces Proposed Offering of $125 Million of Convertible Senior Notes Due 2019 PR Newswire BUENA, N.J., Dec. 9, 2014 BUENA, N.J., Dec. 9, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or the "Company") announced today that, subject to market and other conditions, it intends to offer... More...>>
12/02/20148:00AMPRNUSIGI Laboratories To Present At Piper Jaffray 26th Annual Healthcare Conference On December 2, 2014
IGI Laboratories To Present At Piper Jaffray 26th Annual Healthcare Conference On December 2, 2014 PR Newswire BUENA, N.J., Dec. 2, 2014 BUENA, N.J., Dec. 2, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE Amex: IG), a New Jersey based specialty generic pharmaceutical company, will be presenting today at the Piper Jaffray... More...>>
12/01/20148:00AMPRNUSIGI Laboratories, Inc. Announces 8th ANDA Submission Of 2014
IGI Laboratories, Inc. Announces 8th ANDA Submission Of 2014 IGI Now Has Nineteen Applications Pending at the FDA PR Newswire BUENA, N.J., Dec. 1, 2014 BUENA, N.J., Dec. 1, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted... More...>>
11/24/20148:00AMPRNUSIGI Laboratories, Inc. Announces ANDA Submission
IGI Laboratories, Inc. Announces ANDA Submission PR Newswire BUENA, N.J., Nov. 24, 2014 BUENA, N.J., Nov. 24, 2014 /PRNewswire/ -- IGI Laboratories, Inc. (NYSE MKT: IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted an additional abbreviated new drug application (ANDA) to... More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us amex ig150425 08:31